Mesenchymal niches of bone marrow in cancer

Clinical and Translational Oncology

Volumn 13, Issue 9, 2011, Pages 611-616

  Abarrategi, Ander ^a   Mariñas Pardo, Luis ^a,b   Mirones, Isabel ^a   Rincón, Esther ^a   García Castro, Javier ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Bone marrow; Mesenchymal stem cells; Metastasis; Niche; Tumorigenesis; Tumour microenvironment

Indexed keywords

BORTEZOMIB; CARBOPLATIN; CHEMOKINE RECEPTOR CXCR4; DEXAMETHASONE; INTERLEUKIN 6; PACLITAXEL; STROMAL CELL DERIVED FACTOR 1; ANTINEOPLASTIC AGENT;

ARTICLE; BONE MARROW METASTASIS; CANCER CELL DESTRUCTION; CANCER GROWTH; CANCER RESISTANCE; CARCINOGENESIS; CELL ACTIVITY; CELL ADHESION; CELL FATE; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; DRUG RESPONSE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; INTRACELLULAR SIGNALING; MESENCHYMAL STEM CELL; NONHUMAN; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANIMAL; BONE MARROW CELL; CYTOLOGY; DRUG EFFECT; DRUG RESISTANCE; METASTASIS; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW; STEM CELL NICHE;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; DRUG RESISTANCE, NEOPLASM; HUMANS; MESENCHYMAL STEM CELLS; NEOPLASM METASTASIS; NEOPLASMS; STEM CELL NICHE; TUMOR MICROENVIRONMENT;

EID: 84855398570     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0706-x     Document Type: Article

References (78)

1. Hutchinson GE (1957) Concluding remarks. Cold Spring Harbor Symp Quant Biol 22:415-427
2. Witz IP (2008) Yin-yang activities and vicious cycles in the tumor microenvironment. Cancer Res 68:9
3. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6:392-401
4. Li H, Fan X, Houghton JM (2007) Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 101:805-815 (Pubitemid 47040863)
5. Mundy GR (2002) Metastasis: metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584-593 (Pubitemid 37328925)
6. Ehninger A, Trumpp A (2011) The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 208: 421
7. Yin T, Li L (2006) The stem cell niches in bone. J Clin Invest 116:1195
8. Voog J, Jones DL (2010) Stem cells and the niche: a dynamic duo. Cell Stem Cell 6:103-115
9. Mendez-Ferrer S, Michurina TV, Ferraro F et al (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829-834
10. Bergfeld SA, DeClerck YA (2010) Bone marrowderived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev 29: 249-261
11. Moore KA, Lemischka IR (2006) Stem cells and their niches. Science 311:1880
12. Li L, Neaves WB (2006) Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66:4553
13. Scadden DT (2006) The stem-cell niche as an entity of action. Nature 441:1075-1079 (Pubitemid 43990719)
14. Shiozawa Y, Havens AM, Pienta KJ, Taichman RS (2008) The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites. Leukemia 22:941-950 (Pubitemid 351689875)
15. Mohseny AB, Hogendoorn PCW (2011) Concise review: mesenchymal tumors: when stem cells go mad. Stem Cells 29:397-403
16. Tang N, Song WX, Luo J et al (2008) Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res 466:2114-2130
17. Lin PP, Wang Y, Lozano G (2011) Mesenchymal stem cells and the origin of Ewing's sarcoma. Sarcoma doi.10.1155/2011/276463
18. Garrett RW, Emerson SG (2009) Bone and blood vessels: the hard and the soft of hematopoietic stem cell niches. Cell Stem Cell 4:503-506
19. Horowitz MC, Bothwell ALM, Hesslein DGT et al (2005) B cells and osteoblast and osteoclast development. Immunol Rev 208:141-153 (Pubitemid 41746390)
20. Raaijmakers M (2011) Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system. Haematologica 96: 1041-1048
21. Carlesso N, Cardoso AA (2010) Stem cell regulatory niches and their role in normal and malignant hematopoiesis. Curr Opin Hematol 17:281-286
22. Perry JM, Li L (2007) Disrupting the stem cell niche: good seeds in bad soil. Cell 129:1045-1047 (Pubitemid 46891049)
23. Lindemann RK (2008) Stroma-initiated hedgehog signaling takes center stage in B-cell lymphoma. Cancer Res 68:961
24. Scupoli MT, Donadelli M, Cioffi F et al (2008) Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/ CXCR4 axis and the NF-κB and JNK/AP-1 pathways. Haematologica 93:524
25. Kurtova AV, Tamayo AT, Ford RJ, Burger JA (2009) Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specifi c targeting. Blood 113: 4604
26. Ayala F, Dewar R, Kieran M, Kalluri R (2009) Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 23:2233-2241
27. Colmone A, Amorim M, Pontier AL et al (2008) Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 322:1861
28. Cook G, Dumbar M, Franklin IM (1997) The role of adhesion molecules in multiple myeloma. Acta Haematol 97:81-89 (Pubitemid 26413952)
29. Faid L, Riet I, Waele M et al (1996) Adhesive interactions between tumour cells and bone marrow stromal elements in human multiple myeloma. Eur J Haematol 57:349-358 (Pubitemid 27008286)
30. Thomas X, Anglaret B, Magaud JP et al (1998) Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma. Leuk Lymphoma 32:107-119 (Pubitemid 29086388)
31. Michigami T, Shimizu N, Williams PJ et al (2000) Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and α4β1- integrin enhances production of osteoclast-stimulating activity. Blood 96:1953-1960 (Pubitemid 30661083)
32. Damiano JS, Cress AE, Hazlehurst LA et al (1999) Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 93: 1658-1667 (Pubitemid 29102494)
33. Walkley CR, Olsen GH, Dworkin S et al (2007) A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor [gamma] defi ciency. Cell 129:1097-1110 (Pubitemid 46908696)
34. Walkley CR, Shea JM, Sims NA et al (2007) Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 129:1081-1095 (Pubitemid 46908695)
35. Walkley CR, Shea JM, Sims NA et al (2007) pRb extrinsically regulates hematopoietic stem cells via myeloid cell-bone marrow microenvironment interactions. Cell 129:1081
36. Stavroulaki E, Kastrinaki MC, Pontikoglou CG et al (2011) Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1. Stem Cells Dev doi:10.1089/scd.2010.0425
37. Raaijmakers MH, Mukherjee S, Guo S et al (2010) Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464:852-857
38. Flores-Figueroa E, Arana-Trejo RM, Gutierrez-Espindola G et al (2005) Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. Leuk Res 29:215-224 (Pubitemid 39647516)
39. Garayoa M, Garcia JL, Santamaria C et al (2009) Mesenchymal stem cells from multiple myeloma patients display distinct genomic profi le as compared with those from normal donors. Leukemia 23:1515-1527
40. Corre J, Mahtouk K, Attal M et al (2007) Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia 21:1079-1088 (Pubitemid 46672085)
41. Streubel B, Chott A, Huber D, Exner M (2004) Lymphoma-specifi c genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med 351:250-259 (Pubitemid 38916042)
42. Menendez P, Catalina P, Rodriguez R et al (2009) Bone marrow mesenchymal stem cells from infants with MLL-AF4 acute leukemia harbor and express the MLL-AF4 fusion gene. J Exp Med 206:3131-3141
43. Sung SY, Hsieh CL, Law A et al (2008) Coevolution of prostate cancer and bone stroma in threedimensional coculture: implications for cancer growth and metastasis. Cancer Res 68:9996-10003
44. Cogle CR, Theise ND, Fu DT et al (2007) Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry. Stem Cells 25:1881-1887 (Pubitemid 47258166)
45. Quante M, Tu SP, Tomita H et al (2011) Bone marrow-derived myofi broblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 19:257-272
46. Patenaude A, Parker J, Karsan A (2010) Involvement of endothelial progenitor cells in tumor vascularization. Microvasc Res 79:217-223
47. Mishra PJ, Mishra PJ, Glod JW, Banerjee D (2009) Mesenchymal stem cells: fl ip side of the coin. Cancer Res 69:1255
48. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674
49. Fang S, Salven P (2010) Stem cells in tumor angiogenesis. J Mol Cell Cardiol 50:290-295
50. Butler JM, Kobayashi H, Rafii S (2010) Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 10:138-146
51. Liu S, Ginestier C, Ou SJ et al (2011) Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 71:614-624
52. McLean K, Gong Y, Choi Y et al (2011) Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest DOI10.1172/JCI45273
53. Catena R, Luis-Ravelo D, Anton I et al (2011) PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis. Cancer Res 71:164-174
54. Sohara Y, Shimada H, Minkin C et al (2005) Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells. Cancer Res 65: 1129-1135 (Pubitemid 40270134)
55. Chantrain CF, Feron O, Marbaix E, DeClerck YA (2008) Bone marrow microenvironment and tumor progression. Cancer Microenviron 1:23-35
56. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331:1559-1564
57. Karnoub AE, Dash AB, Vo AP et al (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557-563 (Pubitemid 47525152)
58. Shinagawa K, Kitadai Y, Tanaka M et al (2010) Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer 127:2323-2333
59. Meads MB, Hazlehurst LA, Dalton WS (2008) The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res 14:2519-2526
60. Sneddon JB, Werb Z (2007) Location, location, location: the cancer stem cell niche. Cell Stem Cell 1:607-611 (Pubitemid 350215340)
61. LaBarge MA (2010) The difficulty of targeting cancer stem cell niches. Clin Cancer Res 16:3121-3129
62. Frassanito MA, Cusmai A, Iodice G, Dammacco F (2001) Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis. Blood 97:483-489 (Pubitemid 32060334)
63. Voorhees PM, Chen Q, Kuhn DJ et al (2007) Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma. Clin Cancer Res 13: 6469-6478 (Pubitemid 350075037)
64. Duan Z, Foster R, Bell DA et al (2006) Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res 12:5055-5063 (Pubitemid 44453331)
65. Alsayed Y, Ngo H, Runnels J et al (2007) Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)- dependent migration and homing in multiple myeloma. Blood 109:2708-2717 (Pubitemid 46482062)
66. Juarez J, Pena AD, Baraz R et al (2007) CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment. Leukemia 21:1249-1257 (Pubitemid 46831814)
67. Spiegel A, Kollet O, Peled A et al (2004) Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling. Blood 103:2900-2907 (Pubitemid 38451658)
68. Ratajczak MZ, Zuba-Surma E, Kucia M et al (2006) The pleiotropic effects of the SDF-1- CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20:1915-1924 (Pubitemid 44614878)
69. Yoon Y, Liang Z, Zhang X et al (2007) CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models. Cancer Res 67:7518-7524 (Pubitemid 47206582)
70. Tavor S, Petit I, Porozov S et al (2004) CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res 64:2817-2824 (Pubitemid 38500620)
71. Sanz-Rodriguez F, Hidalgo A, Teixido J (2001) Chemokine stromal cell-derived factor-1α modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fi bronectin and VCAM-1. Blood 97:346-351 (Pubitemid 32060316)
72. Stupp R, Ruegg C (2007) Integrin inhibitors reaching the clinic. J Clin Oncol 25:1637-1638 (Pubitemid 46797938)
73. Miller DH, Khan OA, Sheremata WA et al (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 348:15-23 (Pubitemid 36026342)
74. Iwamoto S, Mihara K, Downing JR et al (2007) Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest 117:1049-1057 (Pubitemid 46556761)
75. Garrido SM, Appelbaum FR, Willman CL, Banker DE (2001) Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). Exp Hematol 29: 448-457 (Pubitemid 32297669)
76. Kurtova AV, Balakrishnan K, Chen R et al (2009) Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 114:4441-4450
77. Balakrishnan K, Burger JA, Quiroga MP et al (2010) Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells. Blood 116:1083-1091
78. Ishikawa F, Yoshida S, Saito Y et al (2007) Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 25:1315-1321 (Pubitemid 350076512)